Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

Amerisource Health Services LLC recalls Duloxetine Delayed-Release Capsules USP

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
CGMP Deviations: Presence of N-nitroso-duloxetine impurity above the recommended interim limit.
Products
  • Duloxetine Delayed-Release Capsules USP
Where it was sold

Nationwide in the USA

Nationwide

Units affected
21,262 bottles
About this recall
Duloxetine Delayed-Release Capsules USP, 30 mg, Rx only, 30 count bottles, Manufactured by: Aurobindo Pharma Limited, Hyderabad-500 090, India, For BluePoint Laboratories NDC 68001-414-04